The company official said sales in drug stores are stable, but the wholesale segment might register some declines, because of delayed payments.
Gedeon posted sales of EUR137.3 million in Romania last year, 14% of the group’s overall sales.
Locally, the group holds a medicine plant in Targu-Mures, drug wholesaler Pharmapharm and a network that includes 119 pharmacies.
Bogsch added Gedeon Richter will invest EUR5-10 million this year to widen production capacity at the Targu-Mures plant.
Some 25% of the company’s output in Romania is exported, and this percentage may rise to 30% in the near future.
Romania’s pharmaceutical market widened by 18.7% last year, to EUR9.62 billion, according to market research firm Cegedim.
The Gedeon Richter group has over 10,200 employees and it has posted overall sales of EUR998.2 million last year.